The predictive value of TILs irrespective of breast cancer subtype was confirmed in an analysis performed by the German Breast Cancer Group, where high levels of TILs predicted for higher pCR rates in patients with luminal, HER2 + and triple-negative disease [43]. This evidence concerns the gene ERBB2 and breast carcinoma.